However, this therapeutic strategy, as well as others designed to inhibit the TWEAK:Fn14 interaction [27, 45, 46], may need to be re-considered since, as mentioned above, TWEAK:Fn14 engagement in certain cancer cell lines can induce beneficial “anti-tumorigenic/metastatic” cellular responses. This evidence concerns the gene TNFRSF12A and cancer.